A multicenter study to describe the immunogenic epitope(s) of factor VIII in previously treated patients with congenital hemophilia A who develop de novo factor VIII inhibitorswhile receiving factor VIII infusion therapy.

• Conditions: PATIENTS WITH CONGENITAL HEMOPHILIA A; MedDRA version: 6.1Level: PTClassification code 10016080

• Registration Number: EUCTR2004-000219-24-IT
• Lead Sponsor: WYETH LEDERLE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-11-09
• Last Update Posted: 1 May 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Descrivere i patterns di anticorpi e degli epitopi associati in un sottogruppo di pazienti affetti da emofilia A che soddisfino i criteri di inclusione del protocollo, utilizzando la metodologia descritta in questo protocollo. <br>;Secondary Objective: ;Primary end point(s): Descrivere i patterns di anticorpi e degli epitopi associati in un sottogruppo di pazienti affetti da emofilia A che soddisfino i criteri di inclusione del protocollo, utilizzando la metodologia descritta in questo protocollo.